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 Introduction: Right ventricular dysfunction is associated with numerous smoking-related illnesses 
including chronic obstructive pulmonary disease (COPD) where it is present even in absence of 
pulmonary hypertension. It is unknown if exposure to cigarette smoke has direct effects on RV function 
and cardiac fibroblast proliferation or collagen synthesis. In this study, we evaluated cardiac function 
and fibrosis in mice exposed to cigarette smoke (CS) and determined mechanisms of smoke-induced 
changes in cardiac fibroblast signaling and fibrosis. 
Methods: AKR mice were exposed to 6 weeks cigarette smoke followed by echocardiography and 
evaluation of cardiac hypertrophy, collagen content, and pulmonary muscularization at study 
conclusion. Proliferation and collagen content were evaluated in primary isolated rat cardiac fibroblasts 
(CF) exposed to cigarette smoke extract (CSE) or nicotine. Markers of proliferation, fibrosis, and 
proliferative signaling were determined by immunoblot or Sircol collagen assay.  
Results: Mice exposed to CS had significantly decreased RV function as determined by TAPSE. There 
were no changes in LV parameters. RV collagen content was significantly elevated but there was no 
change in RV hypertrophy or pulmonary vascular muscularization. CSE directly increased cardiac 
fibroblast proliferation and collagen content in CF. Nicotine alone reproduced these effects. CSE and 
nicotine-induced fibroblast proliferation and collagen content was mediated through α7 nicotinic 
acetylcholine receptors and was dependent on PKC-α, PKC-δ, and reduced p38-MAPK phosphorylation. 
Conclusion: CS and nicotine has direct effects on cardiac fibroblasts to induce proliferation and fibrosis 
which may negatively affect right heart function.   
Introduction 
Right ventricular dysfunction is a poor prognostic marker in a number of cardiopulmonary 
diseases such as heart failure, pulmonary hypertension, and chronic obstructive pulmonary disease 
(COPD). Cigarette smoking is a major cause of COPD. RV dysfunction in smokers is thought to be 
precipitated by vascular remodeling associated with COPD resulting in pulmonary hypertension and 
subsequently increased RV afterload (12, 22). However, recent evidence has shown that RV dysfunction 
can be present in COPD patients without pulmonary hypertension (12). RV dysfunction and failure is 
associated with increased RV fibrosis (2), demonstrated in autopsy specimens and in animal models of 
RV failure (2, 11). Myocardial fibrosis is mediated by proliferation and activation of cardiac fibroblasts. 
However, it is unknown if exposure to cigarette smoke has direct effects on RV function, cardiac 
fibroblast proliferation, or collagen synthesis.  
 Cigarette smoke is a complicated chemical mixture. The effects of cigarette smoke on cellular 
function have been attributed to various components such as nicotine, reactive oxygen species (ROS), 
and reactive aldehydes, amongst others. In endothelial cells, exposure to CSE induces apoptosis via 
reactive oxygen species and reactive aldehydes (6, 24). CSE can also promote increased apoptosis of 
cardiomyocytes (7, 34). In contrast, in cancer cells, nicotine may promote tumor cell proliferation and 
survival (25). Furthermore, nicotine is fibrogenic in multiple organs including the lungs and kidneys (13). 
However, the effect of exposure of cigarette smoke constituents on ventricular fibroblasts and the 
underlying mechanism(s) remain unclear. 
In this study, we sought to evaluate the effect of cigarette smoke exposure on right ventricular 
function. Furthermore, we sought to determine the effects of cigarette smoke on primary cardiac 
fibroblast proliferation and elucidate the underlying mediator and the mechanism. We demonstrate 
that CS smoke exposure in mice increases RV collagen content and significantly reduces RV function in 
the absence of RV hypertrophy and vascular remodeling. In addition, nicotine exposure recapitulates the 
effect of CS on cardiac fibroblasts causing increased fibroblast proliferation and collagen content 
mediated via α7 nicotinic acetylcholine receptor (nAChR) activation.  
  
Materials and Methods: 
Materials. All materials were obtained from Sigma (St. Louis, MO) unless otherwise noted. Collagenase II 
and DNAse were purchased from Worthington (Lakewood, NJ). α-Smooth muscle actin (α-SMA, ab7817) 
antibody and α-Bungarotoxin (α-BTX) were purchased from Abcam (Cambridge, MA). Alda-1 was 
purchased from EMD Millipore (Billerica, MA). The vectors encoding dominant negative cDNA for PKC-δ 
(pHACE-PKCδK376R) and PKC-α (pHACE-PKCαK368R) were gifts from Bernard Weinstein (Addgene plasmids 
#16389 and #21235, respectively, Cambridge, MA(27)) . cDNA for green fluorescent protein (pGFP-C1) 
was obtained from Clontech (Mountain View, CA). Sircol collagen assay was purchased through Accurate 
(Westbury, NY). Antibodies against phosphorylated Erk (T202/Y204, #9101), phosphorylated p38 (T180/Y182, 
#9125), phosphorylated Akt (T308, #9272), total Erk (#9102), total p38 (#9212), and total Akt (#9272) were 
purchased through Cell Signaling (Beverly, MA). α7 nAChR siRNA (sc-270402), control siRNA-FITC (sc-
36869), antibodies for HA (sc-805), PKC-α (sc-208), PKC-δ (sc-8402), PKC-βII (sc-210), Procollagen (sc-
8787), α7 nAChR (sc-554), caspase-3 (9662) and PCNA (sc-25280) were purchased from Santa Cruz 
Biotechnology (Dallas, TX). von Willebrand Factor antibody (#2022-04) was purchased from Dako 
(Carpinteria, CA). Lipofectamine3000 was purchased through Life Technologies (Grand Island, NY). 
Animals. All animal protocols were approved by the Institutional Animal Care and Use Committee of the 
Providence VA Medical Center and comply with the Health Research Extension Act, US Public Health 
Service, and US National Institutes of Health Policy (protocols 2010-026 and 2013-010).  Male AKR mice 
ages 6-8 weeks purchased from Jackson Laboratory were either exposed to room air (RA) or cigarette 
smoke (CS) for six weeks at 6 hours per day, 4 days a week using a TE-10 mouse smoking machine (Teague 
Enterprises, Woodland, CA) with 3R4F reference cigarettes (University of Kentucky, Tobacco Research 
Institute, Lexington, KY) as previously described (24). The smoking machine produced a mixture of 89% 
sidestream and 11% mainsteam smoke and the chamber was monitored for 120 mg/m3 of total suspended 
particulate matter. After 6 weeks, mice were weighed, and were subjected to either transthoracic 
echocardiography or in vivo hemodynamic measurements and then euthanized. These studies were 
performed in two cohorts with the all animals in the first groups receiving echocardiography and all 
animals in the second group subjected to invasive hemodynamics. Lung and heart tissue were collected. 
Lungs were fixed with 10% formalin at 25 cm of H2O pressure, paraffin embedded, and sectioned for α-
SMA/vWF staining. Hearts were fixed in formalin, paraffin embedded, and sectioned for lectin and 
picrosirius staining. 
 Adult Sprague-Dawley rats 250-300 g purchased from Charles River (Wilmington, MA) were used 
for cardiac fibroblast isolations (see below).  
Echocardiographic Measurements. A subset of  animals were anesthetized with continuous isoflurane 
inhalation (1.5-3%) and transthoracic echocardiography was performed as described (5). A 40 MHz linear 
array transducer was used (Vevo 2100, VisualSonics, Toronto, ON, Canada). Two-dimensional, Doppler, 
and M-mode recordings were obtained to measure LV fractional shortening and LV and RV dimensions. 
The pulsed-wave Doppler recording at the right ventricular overflow tract was used to measure pulmonary 
acceleration time (PAT). Tricuspid annular plane systolic excursion (TAPSE) was measured by use of M-
mode across the tricuspid valve annulus at the RV free wall. TAPSE was determined by measuring the 
excursion of the tricuspid annulus from its highest position to the peak descent during ventricular systole. 
Tissue Doppler was used to measure the early diastolic velocity of the septum (at mitral annulus) and RV 
lateral wall (at tricuspid annulus).  
In Vivo Hemodynamics. RV systolic pressure (RVSP), LV systolic pressure (LVSP), and pulmonary artery 
systolic pressure (PASP) were measured under isoflurane anesthesia (1.5-2%) using an opened-chest 
technique. After the chest is opened, a high-fidelity pressure-volume 1.0F catheter was inserted into a 
puncture to apex of the LV and pressure measurements were recorded for 15 sec. Subsequently, the same 
catheter was inserted into the apex of the RV and pressure measurements were recorded for another 15 
sec. The catheter was then guided into the pulmonary artery just past the pulmonic valve to record the 
PAP for 15 sec. Mean PAP (MPAP) was obtained by utilizing the equation: (PASP – 2PADP)/3, where PADP 
is the PA Diastolic Pressure. The animal was then euthanized and tissue was collected for further analysis. 
Pulmonary Muscularization. Paraffin embedded lung tissue was sectioned and stained for α-smooth 
muscle actin and von-Willebrand factor (vWF) as previously described (4). Tissue sections were then 
scanned into an Aperio CS slide scanner at 20x magnification.  50 equally sized fields were marked onto 
the tissue image and scored for colocalized staining of α-SMA and vWF.  Scoring was categorized as 
follows: “none” if no α-SMA staining colocalized with vWF, “partial” if less than 50% α-SMA staining 
colocalized with vWF, and “complete” muscularization if greater than 50% α-SMA staining colocalized 
with vWF. 
Picrosirius Red staining and Coronary Vessel Counts: Paraffin-embedded heart tissue was sectioned and 
deparaffinized.  Picrosirius stained slides  were imaged using a Nikon Eclipse-NI microscope with 20X 
objective, images were taken in the red (594 nm)  and green fluorescent (488 nm) channels as well as 
brightfield.   Three images each were taken from the RV, LV, and septum from each heart.  Picrosirius 
Red fluoresces in the red channel  and quenches green autofluorescence . Therefore, analysis of 
picrosirius red positive stained area was performed by  subtraction of the green fluorescence signal from 
the red fluorescence signal (Nikon Image Software - Elements) similar to previously published protocols 
(31). ImageJ was then used to threshold the subtracted fluorescent Picrosirius red stained image.  
Thresholded images were used for % area quantiation and the data was normalized to the respective RA 
control.  For coronary microvessel analysis antigen retrieval was performed with boiling 10 mM sodium 
citrate and 0.05% Tween 20, pH 6.0 for 10 min.  Sections were then blocked with 5% BSA in PBS and 
incubated overnight with Isolectin GS-IB4, Alexa Fluor-488 Conjugate (Thermo Scientific  #I21411), in 
2.5% BSA at 4°C. Sections were then mounted with coverslips using Prolong Gold with DAPI imaged with 
a fluorescent Nikon Eclipse E400 microscope. Equal-size areas were then counted manually for positive 
staining of lectins for microvascular vessels at 20X magnification. Averaged vessel counts were 
normalized to mm2. 
Collagen Content Measurement. Collagen content was measured using Sircol collagen dye binding assay 
per manufacturer’s instructions. Equal amounts of protein or homogenates were mixed with equal 
volume of Sircol dye reagent for 30 min with agitation. The collagen-dye complex was centrifuged at 
12,000 rpm for 10 min and unbound dye was aspirated. The remaining pellet was washed with ice cold 
acid-salt wash reagent (acetic acid, sodium chloride, and surfactants). Samples were then centrifuged 
again at 12,000 rpm for 10 min. The wash reagent was aspirated and the remaining pellet was dissolved 
by adding the alkali reagent (0.5 M sodium hydroxide). After 5 min incubation, collagen content was 
measured using absorbance at 555 nm. 
Cardiac Fibroblast Isolation. Adult rat cardiac fibroblasts were isolated as previously described (35).  
Briefly, adult Sprague-Dawley rats (250-300 g) were euthanized with continuous inhalation of 5.0% 
isoflurane.  Hearts were immediately excised, trimmed of extra-aortic tissue, and retrogradely perfused 
for 2 min in Krebs-Henseleit (KH) Buffer at 37°C and then switched to enzyme buffer 1 (KH buffer 
containing 0.3 mg/mL collagenase II, 0.3 mg/mL hyaluronidase, and 50 μM CaCl2) for 18 mins. After 
perfusion, the ventricular tissue was excised and in some cases as indicated in results (Figure 4G) was 
divided into LV and RV tissue. Myocardial tissue was minced with scissors and further digested in enzyme 
buffer 2 (enzyme buffer 1 supplemented with trypsin IX 0.6 mg/mL, deoxyribonuclease 0.6 mg/mL, and 
increased CaCl2 to 500 μM) at 37°C for 18 min in a shaking waterbath. The digestion was stopped with the 
addition of 10 mL of DMEM supplemented with 10% FBS, penicillin, and streptomycin (complete media), 
filtered through a 200 μm nylon mesh, and centrifuged at 500 rpm for 5 min. The supernatant was 
removed and centrifuged again at 2000 rpm for 5 min. The resulting pellet was resuspended in complete 
media and plated into four 10 cm dishes. The media was changed after two hours to remove cellular debris 
and unbound cells. Fibroblast purity was at least 95% after plating for 24 hours and washing with media. 
This method previously demonstrated a fibroblast population which stained positive for vimentin and 
minimal amounts of vWF and smooth muscle myosin and actin in low passage cells(P0-P2) (35).  Cells were 
allowed to grow to confluency within 2-3 days before being passaged for in vitro experiments. Only 
Passage 1 (P1) cells were used in this study.  
Myocyte Contractility. The mechanical properties of the cardiomyocytes were assessed using an IonOptix 
Myocam System (IonOptix Inc., Milton, MA) as described previously(14). Unloaded cardiomyocytes 
isolated from each group of mice were placed on a glass slide and allowed to adhere for 5 min, then 
imaged with an inverted microscope and perfused with Tyrode's buffer at 37 °C. Cardiomyocytes were 
paced with 10 V, 4 ms squarewave pulses at 1.0 Hz, and data presented as percent length change. 
Cigarette Smoke Extract. Cigarette smoke extract (CSE) was prepared as previously described (18). 
Mainstream smoke from 3R4F cigarettes was drawn into 30 mL of PBS by vacuum. Each cigarette was lit 
for 5 mins with a total of five cigarettes being used. This was considered 100% CSE. Control solution was 
prepared by drawing unlit cigarettes into PBS. CSE and control solutions were used immediately. Final 
concentrations of CSE are expressed as percent values (the ratio of CSE to total medium volume). The pH 
and color of the CSE was noted after use to maintain consistency. 
In vitro Experiments. Subconfluent (60-70%) P1 cells were exposed to serum-free DMEM supplemented 
with 10 μg/mL insulin, 5.5 μg/mL transferrin, and 5 ng/mL sodium selenite (ITS, Corning, Corning, NY) 
and penicillin and streptomycin. After 24 hr, cells were then pretreated with inhibitor for 30 min and 
then treated with either PBS (CSE vehicle)/CSE or ethanol (nicotine vehicle)/nicotine (600 nM or unless 
otherwise noted) for another 24 hr. For proliferation assays, cells were trypsinized and counted with a 
hemocytometer. For cell viability assays, cells were loaded with the tetrazolium dye MTT for 2-4 hr. 
Media was removed and cells were washed with PBS. MTT detergent (isopropanol/HCl) was then added 
and absorbance was read at 590 nm after an hour with a multiplate reader (BioTek). 
Western Immunoblotting. RV and LVS from mice were homogenized at 4°C in homogenization buffer (20 
mM HEPES, 250 mM sucrose, 100 mM NaCl, 0.2 mM EDTA, 0.2 mM EGTA, 200 μM PMSF, 0.5 mM DTT, 1 
μM leupeptin, 1 μM aprotinin, and phosphatase inhibitor cocktail III). Homogenates were then 
centrifuged at 5,000 rpm for 10 min at 4°C. The pellet was discarded and supernatant was then 
centrifuged again at 15,000 rpm for 10 mins at 4°C. Supernatants were used for total protein analysis. 
Cardiac fibroblasts from the in vitro studies were collected in radioimmunoprecipitation assay buffer 
(RIPA) as previously described (29) and incubated on ice for 10 min prior to centrifugation for 10 min at 
15,000 rpm. Protein concentration was determined using Bradford-Lowry Assay (Biorad). Proteins (50 
μg/lane) were resolved on 7.5% (procollagen) and 10% (Erk, PKCs, PCNA, HA, Akt, p38) separating gels 
by SDS-PAGE. Resolved proteins were transferred to polyvinylidene fluoride membrane and immunoblot 
analysis was performed by appropriate antibody dilution of 1:1,000 for all antibodies with the exception 
of procollagen and HA (1:200). Blots were then incubated with the proper HRP-conjugated secondary 
(SCBT) for 1 hr at RT and chemiluminescence generated with Bio-Rad Clarity. Blots were imaged with a 
film developer or GE Healthcare ImageQuant. Equal loading was confirmed by probing for vinculin 
(1:3,000) or actin (1:1,000). Quantitative densitometry was performed by use of the public domain 
ImageJ program.   
cDNA and siRNA transfections in Cardiac Fibroblasts. Cardiac fibroblasts were transiently transfected 
with cDNA (4 μg/well of six-well plate) encoding dominant negative PKC-δ (PKC-δK376R), PKC-α (PKC-
αK368R), or GFP and α7 siRNA (600 nM) or scrambled siRNA (600 nM) using Lipofectamine3000 according 
to manufacturer’s instructions. After 24 hrs post-transfection, cells were quiesced for 24 hrs and then 
used for experiments as described.  
Statistical Analysis 
Statistical tests were either unpaired 2-tailed Student's t-test, One Way ANOVA with Dunnets post-hoc 
test, or Two Way ANOVA with Tukey post-hoc test as appropriate and unless otherwise indicated. All 
data are expressed as mean ± S.E.M unless otherwise indicated.  A p-value < 0.05 was considered 
statistically significant. 
RESULTS: 
CS exposure is associated with RV dysfunction and fibrosis in absence of right ventricular hypertrophy 
and pulmonary vascular remodeling: Exposure to 6 weeks of CS significantly decreased RV function as 
assessed by TAPSE. The TV e’ and E/A ratio were also reduced suggesting the presence of RV diastolic 
dysfunction (Table 1, Figure 1A). There were no significant changes in RV or LV pressures or pulmonary 
artery pressures as assessed by invasive hemodynamics with a pressure catheter (Figure 1B) or estimation 
of PA pressure assessed via pulmonary acceleration time (PAT) (Table 1).  There were no changes in 
systemic blood pressure, heart rate, or other indices of left ventricle systolic or diastolic function (Table 
1, Fig 1). There were also no changes following only 3 weeks of exposure to CS (data not shown). In parallel 
to the changes in RV function, RV collagen content as assessed by Sircol Assay was increased in the CS 
exposed animals at 6 weeks (Figure 2A) but not at 3 weeks (data not shown). This was confirmed by 
increased procollagen expression (Figure 2B) in the RV of CS exposed mice compared to controls. In 
contrast, there was no increase in collagen content or procollagen expression in the left ventricle (Figure 
2A, B). Collagen content of only septal tissue was also evaluated using Sircol assay and no differences were 
found with CS exposure (data not shown).  Collagen content and fibrosis were also evaluated  using 
picrosirius red staining (Figure 2C). Increased levels of collagen staining were apparent in the RV of CS 
exposed mice compared to room air (Figure 2C). Quantitation of picrosirius staining demonstrated 
significant increases only in the RV of CS exposed mice, similar to Sircol Assay (Figure 2D) Although 
collagen content was increased in the RV, there was no gross right or left ventricular hypertrophy (Table 
2) between groups as determined by tissue weight. CS treated animals had overall reductions in both body 
and tissue weights (Table 2); however RV and LV+S/BW ratios remained unchanged. There were also no 
changes in whole heart expression or cleavage of caspase-3 in the RV or LV of either CS or RA animals 
indicating enhanced apoptosis did not contribute to reduced RV function (data not shown). In addition, 
there was no notable presence of coronary microvascular rarefaction as determined by vessel counts in 
CS treated animals (Table 2). There was some evidence of mild air-space disease in CS-smoked animals as 
shown by an increase in alveolar airspace represented by mean linear intercept measured in H&E lung 
cross sections (Table 3). However, evaluation of pulmonary vascular histology did not show any smoke-
induced changes in muscularization of small, medium, or large sized vessels compared to control (Table 
2). Therefore, CS may induce direct effects on RV function and remodeling independent of significant 
changes in afterload, LV dysfunction, and lung vascular remodeling. 
Cigarette smoke extract induced cardiac fibroblast proliferation: The effects of cigarette smoke extract 
(CSE) on fibroblast proliferation were assessed in adult rat cardiac fibroblasts isolated from whole hearts 
(both RV and LV). Interestingly, increasing concentration of CSE resulted in CF proliferation as assessed by 
cell counts (Figure 3A) and cell viability as assessed by MTT assay (Figure 3B) in isolated fibroblasts. There 
was also an increase in the proliferative marker, PCNA (Figure 3C). There were no changes in the ratio of 
cleaved to total caspase-3 indicating effects were not due to reduced apoptosis (data not shown).  
  CSE contains the reactive aldehyde acrolein and reactive oxygen species (ROS) which may 
underlie some of the cardiac effects of CS exposure. Pretreatment of CF with Alda-1, an aldehyde 
dehydrogenase activator, to reduce reactive aldehydes and ROS scavenging with N-acetyl cysteine did not 
inhibit CSE-induced CF proliferation (Figure 3D). Lower doses (100 nM) of both Alda1 and NAC also had 
no effect (data not shown). In contrast, pretreatment with mecamylamine (Mec), a general nicotinic 
acetylcholine receptor (nAChR) antagonist, attenuated the effect of CSE on CF proliferation (Figure 3E).  
Activation of α7 nAChR mediated CF proliferation. Since effects of CSE were mediated via activation of 
nAChRs, we examined if nicotine was sufficient to promote cardiac fibroblast proliferation and increase 
in collagen through nAChR. Similar to CSE, nicotine increased CF proliferation (Figure 4A). Nicotine also 
increased collagen content in a dose-dependent manner (Figure 4 B). 600 nM nicotine also increased 
procollagen expression (Figure 4C). The effective doses of nicotine to induce proliferation were similar to 
those previously measured in the blood of smokers (25-444 nM) (23). Nicotine-induced proliferation was 
blocked by pretreatment with mecamylamine (Figure 4A and B). Similarly, the effect of nicotine was 
blocked by α-bungarotoxin, a specific α7 nAChR antagonist (Figure 4D). Knockdown of α7 nAChR receptors 
with siRNA (Figure 4E) also blocked nicotine-induced proliferation (Figure 4F). To investigate one potential 
cause of RV selective CS-induced fibrosis, α7 nAChR expression was next examined in RV and LV tissue. 
There were no changes in the expression of α7 nAChR (Figure 4G). As fibroblasts used in all the previous 
experiments were from mixed RV and LV populations, we isolated fibroblasts specifically from the LV and 
RV of male and female mice. We found no difference in nicotine-induced proliferation in fibroblasts 
isolated from LV or RV of male or female rats (Figure 4H) (Three Way ANOVA, effect of nicotine p-value < 
0.01, effect of chamber p-value = 0.85, and effect of sex p-value = 0.89, there were no significant 
interactions). The consistent response to nicotine in fibroblasts isolated from whole hearts or specific 
chambers indicates that there are additional physiologic factors or possibly other constituents in CS that 
may positively (RV) or negatively (LV) modulate fibroblast proliferation in vivo following CS exposure. In 
addition, acute nicotine treatment (1 hour) did not cause any direct effects on LV or RV cardiomyocyte 
contractile function (Figure 4I), further supporting the concept that nicotine-induced fibroblast 
proliferation is responsible for impacting cardiac function.  
Nicotine-induced fibroblast proliferation is PKC-α and -δ− dependent. CFs were pretreated with either 
Gö6976, LY333531, or Rottlerin to inhibit classical PKCs, PKC-β, or PKC-δ, respectively (Figure 5A-C).  
Inhibition of PKC-α/β  with Gö6976 (Figure 5A) attenuated nicotine-induced CF proliferation. This effect 
was absent using the PKC-β specific inhibitor LY333531 alone (Figure 5B), indicating effects of Gö6976 
were attributable to inhibition of PKC-α. PKC-δ inhibition (Figure 5C) with rottlerin also attenuated 
nicotine-mediated CF proliferation. Transfection of CF with dominant negative plasmids of PKC-α and -δ 
(Figure 5D-E) also blunted nicotine-induced CF proliferation confirming results with small molecule 
inhibitors. Gö6976 and rottlerin also blocked nicotine-induced increase in collagen content (Figure 5F). 
In addition, immunoblots of RV lysates from smoke exposed mice confirmed a role for PKC signaling in 
vivo with increased expression of PKC-α and -δ compared to RA controls (Figure 5G,H). We did not 
detect any change in PKC expression in the LV (data not shown). 
Nicotine reduces p38 MAPK activation but does not promote other common proliferation signals. We 
next evaluated nicotine-induced changes in downstream pathways related to acute nAChR signaling 
including Erk, Akt, and p38-MAPK (Figure 6A). While no changes were noted in phosphorylation of Erk or 
Akt (Figure 6A), nicotine decreased p38-MAPK phosphorylation after 30 min nicotine exposure (Figure 
6A, B). Decreased p38 phosphorylation in response to nicotine was attenuated by pretreatment with the 
general nAChR antagonist mecamylamine (Figure 6C). 
Nicotine-reduced p38-MAPK activation is mediated by PKC-δ but not PKC-α. Pretreatment of rat 
cardiac fibroblasts with the PKC-α/β inhibitor Gö6976 did not block nicotine-induced reductions in p38-
MAPK activity (Figure 7A and B). In contrast, treatment of cells with rottlerin significantly attenuated 




 The principle findings of this study were the following: 1) that 6 week cigarette smoke exposure 
induced RV dysfunction and fibrosis in mice independent of overt pulmonary remodeling, 2) CS-induced 
pro-fibrotic changes were not found in left ventricular tissue, and 3) nicotine directly induce cardiac 
fibroblast proliferation and collagen content through α7 nAChR dependent PKC-α and -δ signaling.  
 Our results indicate that cigarette smoke directly changes RV function and collagen content. 
Importantly, depressed RV contractile function and enhanced fibrosis observed in this study appeared to 
be independent of remodeling of the pulmonary circulation and increased afterload (as determined by 
PAT, histological examination, and unchanged PA and RV pressures). In addition, we believe that 
nicotine is likely the causative factor of increased RV fibrosis since nicotine application to cardiac 
fibroblasts increased cell proliferation and collagen content. The effects of nicotine on proliferation are 
cell and tissue dependent with enhanced proliferation in certain cancers and increased apoptosis in 
endothelial cells (6, 24, 25). In contrast to endothelial cells, nicotine is known to directly increase 
proliferation in numerous cell types, potentially through activation of nAChR (8, 10, 13). Multiple 
fibroblast types express α7 nAChR (1, 13). To our knowledge, this is the first study demonstrating direct 
effects of nicotine on cardiac ventricular fibroblasts mediated via nAChR. General or specific blockade of 
α7 nAChR with mecamylamine and α-BTX, respectively, or specific knockdown of α7 nAChR was capable 
of blocking the CSE/nicotine-induced cardiac fibroblast proliferation and profibrotic phenotype.   
 Importantly, in the CS-exposed mice, enhanced RV fibrosis and depressed function were not 
associated with an increase in gross RV hypertrophy as assessed by RV/BW ratios. This further indicates 
that the enhanced RV fibrosis and fibroblast proliferation stimulated by CS was independent of 
pulmonary vascular remodeling as increased pulmonary pressures and elevated RV afterload would 
likely be associated with RV hypertrophy and failure as seen in models of COPD and pulmonary 
hypertension (30). CS-induced effects were likely mediated by direct nicotine stimulation of fibroblast 
α7 nAChR. This was supported by direct stimulation of cardiac fibroblast proliferation and collagen 
expression by nicotine in vitro.  In addition, to our knowledge, this is the first report of increased RV 
fibrosis and dysfunction in the absence of simultaneous RV hypertrophy. In this  study, we used AKR 
mice which are prone to CS-induced pulmonary injury. There is no data on use of AKR mice to study 
pulmonary vascular remodeling and right ventricular function that we are aware of to compare with our 
model. Others have reported that with certain strains of mice (e.g. A/J) after 5 months of CS exposure, 
significant vascular remodeling and right ventricular hypertrophy is present. We believe that our model 
may provide a unique insight into development of RV dysfunction in absence of pulmonary hypertension 
in settings of CS exposure as noted in patients with COPD and normal PA pressures(26). Further studies 
are needed to  explore the temporal aspect of progression of air space disease, vascular remodeling and 
right ventricular dysfunction to precisely characterize these relationships in our model of CS exposure. 
 Another important finding of these studies was that depressed cardiac function and fibrotic 
signals in response to cigarette smoke were unique to the RV. It is currently unclear why depressed 
function and fibrotic responses were limited to the RV in CS-exposed mice. Numerous differences have 
been described between right and left ventricle cardiomyocytes as well as whole heart responses to 
different agonists and stimuli (9, 22). However, no studies have documented differences in fibroblast 
specific responses in the two ventricles. Nevertheless, our data clearly indicates that CS induces RV 
fibrosis and RV dysfunction. Importantly, in our isolated cell experiments, fibroblasts isolated from 
either the RV or LV had similar response to nicotine. In numerous disease states, the RV is considerably 
more prone to fibrosis and changes in afterload than the LV (9, 19, 21). Potential explanations for 
differences in LV and RV fibrosis may be that fibroblast proliferative responses are dependent on 
chamber specific hemodynamic stress in vivo possibly related to air space disease, localized 
neurohumoral or immune differences, and any potential up or downregulated systems that interact 
with nAChR signaling. It is also possible that species specific differences in cardiac fibroblast signaling in 
response to nicotine exist between the mice hearts and isolated rat CFs used in this study. Finally, 
crosstalk between cardiac fibroblasts and cardiomyocytes play an important role in modulating 
cardiomyocyte structure and function(15, 28). While nicotine does not have any direct effect on 
cardiomyocyte function, it is possible that the nicotine exposed cardiac fibroblasts may modulate 
cardiomyocyte structure and function contributing to the right ventricular dysfunction observed in 
cigarette smoke exposed animals. Future studies will be needed to differentiate these possibilities and 
the important differences observed in LV and RV fibrotic responses in response to CS.  
 Nicotine-dependent CF proliferation and collagen expression was dependent on α7 nAChR 
signaling through PKCs. α7 nAChRs are ligand gated ion channels which regulate Ca2+ influx in response 
to acetylcholine or nicotine (1, 8, 13). This study supports the idea that nicotine in CS activates α7 
nAChR-mediated Ca2+ influx leading to specific PKC isoform activation and subsequent proliferation and 
fibrosis. The nAChR-mediated Ca2+ influx has been associated with activation of Ca2+ dependent kinases 
to mediate downstream proliferative effects (1). We found that nicotine-induced CF proliferation 
required the Ca2+-dependent PKC-α but did not require the similarly regulated PKC-βII. In addition, the 
novel PKC isoform PKC-δ was also required for nicotine-induced CF proliferation (Figure 5). Upregulation 
of PKCs has been implicated in the pathogenesis of LV heart failure and fibrosis (17, 20) and our data 
indicate that similar PKC signals may be present during cigarette smoke and nicotine-induced RV 
dysfunction. 
 Nicotine-induced increased CF proliferation and collagen expression were associated with 
decreased p38-MAPK phosphorylation which was PKC-δ dependent. The literature regarding p38-MAPK 
and fibrosis is conflicting; however multiple studies support the notion that decreasing p38 activity in 
cardiac fibroblasts is pro-fibrotic. In a hypoxia-induced model of pulmonary hypertension (PAH) in rats, 
we showed that PAH-induced RV fibrosis is associated with increased RV expression of PKC-βII and PKC-
δ (5). RV fibrosis in this model was also associated with decreased p38-MAPK phosphorylation. In 
addition, Angiotensin II (Ang II), which contributes to hypoxia-dependent PAH, directly increases CF 
proliferation and collagen expression. The Ang II-induced fibrotic phenotype in CFs also required PKC-
dependent downregulation of p38-MAPK (5). Furthermore, cardiomyocyte p38-MAPK activation was 
previously shown to be a negative regulator of cardiac hypertrophy. Braz and colleagues demonstrated 
hypertrophy and decreased function in DN-p38-MAPK, DN-MKK3 and DN-MKK6 transgenic mice as well 
as enhanced hypertrophic responses to aortic banding (3). These authors also found that DN-p38-MAPK 
and DN-MKK3 mouse hearts exhibited elevated interstitial fibrosis supporting the hypothesis that 
nicotine-mediated decreases in p38-MAPK activity may be a key signal to promote RV fibrosis. Inhibition 
of p38-MAPK also enhanced NFAT signaling which is a known mediator of hypertrophy. Nicotine was 
recently found to increase NFAT activity in neonatal rat cardiomyocytes (16). In contrast, a role for pro-
fibrotic activities of p38-MAPK has been proposed based on numerous studies identifying p38-MAPK 
signaling as a downstream effector of the pro-fibrotic cytokine TGF-β (32). However, some well 
characterized p38-MAPK inhibitors are also known to inhibit the TGF-β receptor kinase, thus limiting 
interpretation of these studies (33). Future studies are needed to elucidate the mechanism and role of 
reduced p38-MAPK activity in nicotine-induced fibroblast proliferation.    
 Finally, it is noteworthy that nicotine itself is the constituent of cigarette smoke capable of 
inducing proliferation and fibrotic responses in cardiac fibroblasts. This could have serious implications 
for chronic nicotine replacement therapy for smoking cessation or recreational use. Future studies will 
need to determine if nicotine alone can induce the RV fibrosis changes found in CS exposed mice to help 
identify if continuous nicotine replacement is a safe method of smoking cessation or for recreational 
use. Further inquiry into the direct effects of nicotine on RV function and fibrosis in relevant animal 
models and patients will be required.  
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 Legends: 
Figure 1: Assessment of RV and LV function in RA and CS-exposed AKR mice.  A) Representative images 
using echocardiography demonstrating TAPSE, tricuspid annulus e’, and tricuspid valve E/A, n = 6. B) 
Representative hemodynamic tracings obtained with a Millar pressure catheter placed in the RV and the 
LV.  
Figure 2: Analysis of cardiac fibrosis in RV and LV of RA and CS-exposed mice. RV and LV+S tissue of 
mice exposed to CS smoke exhibited increased A) collagen content (sircol) and B) procollagen expression 
Collagen assay n = 5-7, procollagen expression n = 3-4. * indicates p < 0.05 vs room air, Student's t-test. 
Similar increases in fibrosis were apparent with picrosirius red stained paraffin sections Figure 2C shows 
representative images of RA and CS-exposed RV and LV. D) Significantly increased picrosirius staining in 
CS-exposed RV but not LV as determined by quantitation of images (see methods). * indicates p<.05 vs 
respective room air exposed tissue using Students T-test, n = 6-7.  
Figure 3.Effects of CSE on fibroblast proliferation and role of nAChRs. Cardiac fibroblasts isolated from 
rats were quiesced for 24 hours, exposed to cigarette smoke extract (CSE) for 24 hours. A) CSE dose-
dependently increases proliferation (n = 5) and B) cell viability (n = 5). C) CSE increases proliferation 
marker PCNA (n = 5). D) CSE-induced cell proliferation in cardiac fibroblasts was not attenuated by 
activation of aldehyde dehydrogenase (Alda-1) or ROS scavenging (NAC) (n = 5). E) Mecamylamine (Mec, 
20 µM) inhibited CSE-induced fibroblast proliferation (n = 5). Data is normalized to Veh and presented as 
means ± SEM. * indicates p < 0.05 compared to Veh; # indicates p < 0.05 compared to CSE alone .  
Figure 4.  Effect of nicotine on isolated fibroblast proliferation and dependence of a7 nAChR. Nicotine 
promotes increase (A) cell counts (n = 5) and (B) collagen content (n = 5) in cardiac fibroblasts through 
nAChR activation. C) Nicotine also increase procollagen expression (n = 5). D) α−BTX (100 nM) blocks 
nicotine induced proliferation (n = 5). Knock down of α7 nAChR with siRNA (E) blocks nicotine-induced 
proliferation (F) (n = 5). Quiescent cells were pretreated with either vehicle, Mec, α−BTX, or α7 nAChR 
siRNA, followed by vehicle or Nicotine (600 nM) for 24 hrs. Data is normalized to vehicle treatment and 
presented as means ± SEM. * indicates p < 0.05 compared to Veh; # indicates p <0.05 compared to 
Mec/Vehicle. G) There were no differences in expression of α7 nAChR in rat LV and RV tissues (n = 4). H) 
There were no changes in response to nicotine in cardiac fibroblasts isolated from LV or RV or male or 
female rats. Nicotine significantly increased proliferation in all groups compared to respective untreated 
groups (indicated by * p<.05) (n = 3-4 animals/group performed in triplicate, Three Way ANOVA, SNK 
post-hoc) I) There were no significant changes (T-test) in RV or LV cardiomyocyte contractile function 
with acute nicotine treatment . 
 Figure 5: Role of PKC signaling in nicotine-induced fibroblast proliferation: Small molecule inhibitors of 
PKC-α (100 nM) (A) or -δ (3 µM) (C), but not PKC-β (B) block nicotine-induced CF proliferation (n = 5). 
Expression of dominant negative PKC-α (D) or PKC-δ (E) also blocks nicotine-induced CF proliferation (n 
= 5). Inhibition of PKC-α and -δ block nicotine-induced increased collagen content (F) Cells were 
quiesced in serum-free medium for 24 hours prior to nicotine stimulation.  * indicates p < 0.05 using two 
Way ANOVA, SNK post hoc test. G) CS smoke exposed mice have increased expression of PKC-α and -δ in 
RV tissue. A representative blot is shown H) Quantitation of data in G (n=4). 
Figure 6:  Effects of nicotine on phosphorylation of Akt, ERK, and p38-MAPK. A) Nicotine treatment for 
30 minutes does not change Akt or Erk phosphorylation but does acutely decrease phosphorylated p38-
MAPK. Representative blots are shown. B) Quantitation of phospho- and total p38-MAPK from A.  C) 
Reduced p38-MAPK phosphorylation is blocked by the nAChR antagonist mecamylamine. A 
representative blot is shown. n = 5. * indicates p < 0.05 vs vehicle, unpaired t-test.   
Figure 7: Determination of upstream signals regulating nicotine-dependent reduced p38-MAPK 
phosphorylation. A) Inhibition of PKC-α does not reduce p38-MAPK phosphorylation. A representative 
blot is shown. B) Quantitation of results in A. n = 8. C) Nicotine-mediated reduction of p38-MAPK 
phosphorylation is blocked by rottlerin. D) Quantitation of results in C. n = 8. * indicates p < 0.05 vs 
control/vehicle group. # indicates p < 0.05 from both vehicle and nicotine control groups.  Two Way 
ANOVA, Tukey’s test. Any samples in cropped images were run on the same gel with groups irrelevant to 
the manuscript removed.   
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 Parameter Room Air Cigarette Smoke 
PAT (ms) 24.5 ± 2.6 25.9 ± 1.9 
LV Ejection Fraction (%) 57.9 ± 7.1 68.7 ± 3.5 
Mitral Valve E/A 1.5 ± 0.1 1.4 ± 0.1 
Mitral Annulus e' (mm/s) -23.8 ± 1.9 -19.7 ± 3.0 
TAPSE (mm) 1.1 ± 0.1 0.8 ± 0.1* 
Tricuspid Valve E/A 0.68 ± 0.05 0.55 ± 0.03* 
Tricuspid Annulus e' (mm/s) -25.1 ± 0.9 -19.4 ± 2.1* 
Heart Rate (bpm) 370.2 ± 20.5 396.8 ± 24.7 
RVSP (mmHg) 26.3 ± 1.1 27.7 ± 1.7 
LVSP (mmHg) 79.6 ± 7.1 74.5 ± 8.3 
MPAP (mmHg) 12.0 ± 0.9 13.2 ± 1.3 
Table 1: Echocardiographic and in vivo hemodynamic parameters of room air and cigarette smoke 
exposed mice at 6 weeks. n = 6-12, * indicates p < 0.05. PAT: pulmonary acceleration time; TAPSE – 
tricuspid annular plane systolic excursion; RVSP – RV systolic pressure; LVSP – LV systolic pressure; 
MPAP – mean PA pressure 
  
 Table II – Indices of cardiac hypertrophy and coronary vascular density in Room Air and CS-exposed 
animals. n = 5-9 for heart body weights. n = 6-8 for histological analysis. * indicates p < 0.05 
Ventricular Hypertrophy 
 Room Air Cigarette Smoke 
Body Wt (g) 31.46 ± 0.91 26.99 ± 0.76* 
RV (mg) 40.18 ± 2.31 31.50 ± 2.41* 
LVS (mg) 102.62 ± 3.41 90.32 ± 21.2* 
RV/LVS 0.39 ± 0.02 0.35 ± 0.03 
RV/Body Wt 1.28 ± 0.04 1.19 ± 0.10 
LVS/Body Wt 3.30 ± 0.11 3.40 ± 0.06 
Coronary Microvessel Density (vessels/mm2) 
 
Room Air Cigarette Smoke 
RV 1583.2 ± 78.6 1676.2 ± 112.8 
LV 2010.8 ± 82.9 1969.9 ± 120.6 
 
  
Table III – Indices of alveolar and pulmonary vascular muscularization in RA and CS-exposed animals. n = 
4-6 for MLI and n = 3-4 for histological analysis. * indicates p < 0.05. MLI – mean linear intercept 
 
Pulmonary Muscularization 
% Vessels Room Air Cigarette Smoke 
None 41.6 ± 14.9 45.0 ± 6.7 
Partial 36.4 ± 9.4 38.1 ± 3.5 
Complete 22.1 ± 6.1 17.0 ± 4.6 
Alveolar Space 
 Room Air Cigarette Smoke 
MLI 28.9 ± 0.82  32.9 ± 1.18* 
 
